Common Contracts
4 similar Sales Agreement contracts by Tenax Therapeutics, Inc., Glycomimetics Inc, Trillium Therapeutics Inc.
GLYCOMIMETICS, INC. Common Stock (par value $0.001 per share) SALES AGREEMENTSales Agreement • October 7th, 2020 • Glycomimetics Inc • Pharmaceutical preparations • New York
GlycoMimetics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
TRILLIUM THERAPEUTICS INC. $25,000,000 Common Shares SALES AGREEMENTSales Agreement • June 20th, 2018 • Trillium Therapeutics Inc. • Pharmaceutical preparations • New York
Trillium Therapeutics Inc., a corporation organized under the laws of the Province of Ontario, Canada (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
TENAX THERAPEUTICS, INC. SALES AGREEMENTSales Agreement • July 14th, 2015 • Tenax Therapeutics, Inc. • Services-commercial physical & biological research • New York
TENAX THERAPEUTICS, INC. SALES AGREEMENTSales Agreement • February 24th, 2015 • Tenax Therapeutics, Inc. • Services-commercial physical & biological research • New York
